knowledge -WSS

knowledge

author：Wikipedia 2025-08-26 01:21:23 - browse：28

Photo of a doctor holding a cellphone. -- first opinion coverage from STAT — Adobe

Thinking about messaging your physician about a weird rash? You may want to hold off on it. Some hospital systems have started charging patients for digital messages to their doctors via the electronic medical record, either a flat rate (like a copay) or on sliding scale depending on the time or complexity of the physician’s response. Sometimes it’s billed through an insurer, sometimes as a direct cost to the patient. Costs have ranged between less than $10 and $100 for a message.

Now that at least 22 hospital systems have implemented the practice, a great debate has broken out in the medical profession: Is charging patients to send a note to a doctor just common sense or an unjust expense?

In asking family, friends, and colleagues about this, my grandmother’s response was the most enlightening: “I’m surprised doctors ever stopped charging for phone calls!”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Elizabeth Holmes banned from government health programs

WSS

Profiling embryos to choose those with higher IQs is almost a reality

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Nonprofit, backed by Microsoft, to certify AI tools in health care

The tragedy of Johnson & Johnson’s Covid vaccine

Humana cuts profit projections as Medicare Advantage costs soar

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

hotspot

knowledge

explore

Moonlake's readout produced a cash windfall. Risks remain

Boston Scientific acquires urology company Axonics for $3.7 billion

Dobbs anniversary: the lost opportunity of abortion as health care

Prior authorization will have to move faster under new Biden rule

Novavax promises a turnaround & Lilly roils the obesity market

Arena BioWorks launches in Cambridge to speed drug discovery

Duchenne breakthrough therapy leaves behind pioneering families

A preacher's new calling: Diversifying neuroscience research

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Does Paxlovid work in people vaccinated against Covid

focus

Why doctors need education on FDA device approval process

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Life science postdocs should get big pay hike, NIH panel says

Prior authorization will have to move faster under new Biden rule

Merck to acquire Harpoon Therapeutics for $680 million

Readout Newsletter: Merck, J&J, and long Covid

entertainment

hotspot

focus

leisure time